A Phase 1 study of safety and pharmacokinetics of BAX 855 (PEG-rFVIII) in patients with severe hemophilia AD. Bevan,M. Conlan,T. Mant,T. Lissitchkov,P. Chowdary, F. Langer,B. Ewenstein,K. Fukutake, M. Shima,A. Grigorian,R. Kazmi,J. Singer, W. Yen WongHAEMOPHILIA(2013)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要